Perrigo (PRGO) Net Cash Flow Growth (5y) (2018 - 2026)
Perrigo (PRGO) Net Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Perrigo | 1.94 Bn | 1.54 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 18.09% |
| Mar 28, 2026 | -1.75% |
| Dec 31, 2025 | 19.55% |
| Sep 27, 2025 | 49.71% |
| Jun 28, 2025 | -54.67% |
| Mar 29, 2025 | -24.07% |
| Dec 31, 2024 | -78.64% |
| Sep 28, 2024 | 27.60% |
| Jun 29, 2024 | -20.37% |
| Mar 30, 2024 | -18.14% |
| Dec 31, 2023 | 4.41% |
| Sep 30, 2023 | 21.14% |
| Jul 1, 2023 | 76.66% |
| Apr 1, 2023 | -53.82% |
| Dec 31, 2022 | 25.91% |
| Oct 1, 2022 | -18.42% |
| Jul 2, 2022 | 9.24% |
| Apr 2, 2022 | -48.35% |
| Dec 31, 2021 | -15.70% |
| Apr 3, 2021 | -24.07% |